A robust estimation of infliximab pharmacokinetic parameters in Crohn's disease

Eur J Clin Pharmacol. 2015 Dec;71(12):1541-2. doi: 10.1007/s00228-015-1942-8. Epub 2015 Sep 15.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Monoclonal / pharmacokinetics*
  • Antirheumatic Agents / pharmacokinetics*
  • Arthritis, Rheumatoid / complications*
  • Arthritis, Rheumatoid / drug therapy*
  • Female
  • Humans
  • Inflammation / complications*
  • Inflammation / drug therapy*
  • Male

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents